We have located links that may give you full text access.
Exploring the basis of phenotypic diversity in Alzheimer's disease.
BACKGROUND: Alzheimer's Disease (AD) is the most common type of dementia and affects more than 50 million people around the world. Although there is no effective treatment for the disease at the moment, early detection is still critical to start an early management plan and try out various interventions. Besides the stereotypical Amnestic Syndrome, many atypical pehnotypes exist which make accurate early diagnosis challenging.
METHOD: Examined Corticobasal Syndrome (CBS), behavioural variant of Frontotemporal Dementia (bvFTD), Posterior Cortical Atrophy (PCA), and Primary Progressive Aphasia (PPA) cases correlating with AD's onset. As such, this literature review investigated the reasons underpinning the selective regional vulnerability leading to clinical diversity in AD.
RESULT: The majority of AD is sporadic, caused by phosphorylated-tau aggregates and amyloid-β depositions in neurons or extracellular space. Increasing age is the dominant risk factor for AD development and the major genetic risk factor for sporadic AD is ApoE4. A small proportion of AD is familial, due to mutations in APP, PSEN1, and PSEN2 genes. The available research findings suggest that diverse clinical presentations correlated with selective degeneration and pathology development in different brain regions. The different regions with originally pathological alternations of each phenotype may help explain the conundrum of polytropic presentations, that primary motor cortex is significantly affected in CBS, basal ganglia in bvFTD, posterior part of the brain in PCA, and temporoparietal areas in PPA. Research indicates that the presence of ApoE4 is significant for the development of all AD phenotypes. In addition, while some studies reported several famial cases, these are not typically thought to be representative and thus more studies are needed.
CONCLUSION: The diverse clinical phenotypes of AD, including AS, CBS, bvFTD, PCA, and PPA, share similar pathogenesis and genetic factors, but each phenotype has divergent patterns of regional distribution of the pathology.
METHOD: Examined Corticobasal Syndrome (CBS), behavioural variant of Frontotemporal Dementia (bvFTD), Posterior Cortical Atrophy (PCA), and Primary Progressive Aphasia (PPA) cases correlating with AD's onset. As such, this literature review investigated the reasons underpinning the selective regional vulnerability leading to clinical diversity in AD.
RESULT: The majority of AD is sporadic, caused by phosphorylated-tau aggregates and amyloid-β depositions in neurons or extracellular space. Increasing age is the dominant risk factor for AD development and the major genetic risk factor for sporadic AD is ApoE4. A small proportion of AD is familial, due to mutations in APP, PSEN1, and PSEN2 genes. The available research findings suggest that diverse clinical presentations correlated with selective degeneration and pathology development in different brain regions. The different regions with originally pathological alternations of each phenotype may help explain the conundrum of polytropic presentations, that primary motor cortex is significantly affected in CBS, basal ganglia in bvFTD, posterior part of the brain in PCA, and temporoparietal areas in PPA. Research indicates that the presence of ApoE4 is significant for the development of all AD phenotypes. In addition, while some studies reported several famial cases, these are not typically thought to be representative and thus more studies are needed.
CONCLUSION: The diverse clinical phenotypes of AD, including AS, CBS, bvFTD, PCA, and PPA, share similar pathogenesis and genetic factors, but each phenotype has divergent patterns of regional distribution of the pathology.
Full text links
Related Resources
Trending Papers
Revascularization Strategy in Myocardial Infarction with Multivessel Disease.Journal of Clinical Medicine 2024 March 27
Intravenous infusion of dexmedetomidine during the surgery to prevent postoperative delirium and postoperative cognitive dysfunction undergoing non-cardiac surgery: a meta-analysis of randomized controlled trials.European Journal of Medical Research 2024 April 19
The Tricuspid Valve: A Review of Pathology, Imaging, and Current Treatment Options: A Scientific Statement From the American Heart Association.Circulation 2024 April 26
Consensus Statement on Vitamin D Status Assessment and Supplementation: Whys, Whens, and Hows.Endocrine Reviews 2024 April 28
Management of Diverticulitis: A Review.JAMA Surgery 2024 April 18
Interstitial Lung Disease: A Review.JAMA 2024 April 23
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app